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Abstract:  The  objective  of  this  study  was  to  elucidate  the  cytotoxic  mechanism  of 
Compound K, with respect to the involvement of reactive oxygen species (ROS) and the 
mitochondrial  involved  apoptosis,  in  HT-29  human  colon  cancer  cells.  Compound  K 
exhibited a concentration of 50% growth inhibition (IC50) at 20 μg/mL and cytotoxicity in 
a time dependent manner. Compound K produced intracellular ROS in a time dependent 
fashion;  however,  N-acetylcysteine (NAC) pretreatment resulted in the inhibition of this 
effect and the recovery of cell viability. Compound K induced a mitochondria-dependent 
apoptotic  pathway  via  the  modulation  of  Bax  and  Bcl-2  expressions,  resulting  in  the 
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disruption of the mitochondrial membrane potential (Δψm). Loss of the Δψm was followed 
by cytochrome c release from the mitochondria, resulting in the activation of caspase-9, -3, 
and concomitant poly ADP-ribosyl polymerase (PARP) cleavage, which are the indicators 
of caspase-dependent apoptosis. The apoptotic effect of Compound K, exerted via the 
activation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase 
(MAPK),  was  abrogated  by  specific  MAPK  inhibitors.  This study demonstrated that 
Compound K-mediated generation of ROS led to apoptosis through the modulation of a 
mitochondria-dependent apoptotic pathway and MAPK pathway. 
Keywords: Compound K; reactive oxygen species; mitochondrial membrane potential; 
c-Jun NH2-terminal kinase; p38 mitogen-activated protein kinase 
 
1. Introduction 
Reactive oxygen species (ROS) are the by-products of normal cellular oxidative processes, and are 
mainly generated in the mitochondria. They attack lipid membranes, proteins, and DNA, leading to 
serious  cell  damage,  and  regulate  apoptotic  signal  transduction
  [1–3].  Indeed,  ROS  induce  the 
depolarization of the mitochondrial membrane, and lead to increased levels of pro-apoptotic molecules 
in  the  cytosol  [4–6].  Apoptosis  is  followed  by  cell  shrinkage,  nuclear  fragmentation,  membrane 
blebbing,  DNA  fragmentation,  and  finally  the  breakdown  of  the  cell  into  apoptotic  bodies  [7–9]. 
Capases,  a  family  of  cysteine-dependent  aspartate-directed  proteases,  play  a  critical  role  in  the 
initiation and execution of apoptosis [10–12]. Among this family, caspase-9 and -3 are the most crucial 
for the initiation and execution of apoptosis in various cell types [13,14]. Cancer is a disease that 
involves  excessive  proliferation  of  cells  and  insufficient  cell  suicide  via  apoptotic  process.   
[20-O-(β-D-glucopyranosyl)-20(S)-protopanaxadiol] (Compound K, Figure 1) is the main metabolite 
of  protopanaxadiol-type  ginsenoside  formed  in  the  intestine  after  oral  administration  [15–18].  We 
recently reported that Compound K exhibited cytotoxicity through the induction of apoptosis, arrest at 
the G1 phase of cell cycle, and inhibition of telomerase activity in human leukemia cells [19–21]; that 
the combined treatment of Compound K and radiation enhanced the cell death in human lung cancer 
cells  [22];  and  that  Compound  K  induced  apoptosis  in  MCF-7  breast  cancer  cells  through  the 
modulation of AMP-activated protein kinase [23]. The gastrointestinal tract, especially the colon, is 
constantly  exposed  to  ROS  originating  from  endogenous  and  exogenous  sources  [24].  Colorectal 
cancer is  the fourth  most  prevalent carcinoma in western society  and the second cause of  cancer 
death [25].  And  genetic  alterations  by  ROS  are  the  ultimate  underlying  mechanisms  of  colorectal 
carcinogenesis [26,27]. Compound K has been shown to exhibit anti-proliferative effects on colon 
cancer cells, which was mediated through apoptosis [28–30]. Despite evidence of its anti-proliferative 
effects in colon cancer, the cytotoxic mechanism of this effect with respect to the involvement of ROS 
and mitochondrial involved apoptosis, has not been investigated. Our study showed that Compound K   
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significantly induced ROS generation, which in turn led to apoptotic signals including mitochondria-
dependent and caspase-dependent processes. 
Figure  1.  Chemical  structure  of  Compound  K,  [20-O-D-glucopyranosyl-20(S)-
protopanaxadiol]. 
 
2. Results and Discussion 
2.1. ROS-Induced Cytotoxic Effect of Compound K on HT-29 Colon Cancer Cells 
Compound K is an active metabolite of ginsenosides and exhibits anti-tumor effects against various 
types  of  cancer  cells
  [16,17,19–23,28–36].
  In  the  present  study,  we  investigated  the  effects  and 
mechanism of action of Compound K in ROS-mediated apoptosis in HT-29 cancer cells. Although it 
had  been  previously  shown  that  Compound  K  induced  apoptosis  via  a  Ca
2+/calmodulinactivated 
protein  kinase-IV/AMP-activated  protein  kinase  pathway  in  HT-29  colon  cancer  cells
  [28,29], 
Compound  K-induced  ROS-mediated  apoptosis  in  colon  cancer  cells  had  not  been  investigated. 
Several anticancer agents used in the treatment of cancer have been shown to cause increased cellular 
ROS generation [37–39]. Compound K inhibited HT-29 cell growth in a dose-dependent manner at 10, 
20, 30, and 40  μg/mL  at  48 h, and the concentration  effecting 50% growth inhibition  (IC50) was 
20 μg/mL  (Figure  2A).  Compound  K  at  20  μg/mL  also  inhibited  HT-29  cell  growth  in  a 
time-dependent  manner  (Figure  2B),  but  did  not  exhibit  cytotoxicity  in  FHC  normal  colon  cells 
compared  to  HT-29  cells  at  day  2  (Figure  2C).  Intracellular  ROS,  as  signaling  intermediates,  are 
involved  in  cell  death  signal  transduction  pathways.  Compound  K  induced  ROS  generation  as 
compared to control in a time-dependent manner (Figure 3A), and NAC, a distinct antioxidant and 
ROS scavenger, exerted a scavenging effect on the ROS generated by Compound K  (Figure 3B). 
Subsequently, NAC significantly abolished the Compound K-triggered cell death; cell survival was 
increased to 81% in NAC-pretreated, Compound K-treated cells, compared to 53% in cells treated only 
with Compound K (Figure 3C). This result suggests that the ROS generated by Compound K induces 
the cell death. Int. J. Mol. Sci. 2010, 11                  
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Figure 2. Cytotoxic effect of Compound K in human colon cells. Cell viability (A) at the 
indicated concentrations of Compound K at 48 h in HT-29 cancer cells; (B) at the indicated 
times with Compound K at 20 μg/mL in HT-29 cells; (C) at 20 μg/mL of Compound K in 
FHC  normal  colon  cells  and  HT-29  colon  cancer  cells  was  assessed  using  MTT  test. 
*Significantly different from control (p < 0.05). 
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Figure  3.  Intracellular  ROS  generation  induced  by  Compound  K  treatment.   
(A) Intracellular ROS generated by Compound K were detected at indicated times by a 
spectrofluorometer  after  DCF-DA  treatment.  (B)  After  treatment  with  NAC  and/or 
Compound  K,  intracellular  ROS  were  detected  at  24  h  by  spectrofluorometer  after 
DCF-DA treatment. (C) After treatment with NAC and/or Compound K, cell viability was 
assessed  by  MTT  assay.  *Significantly  different  from  control  (p  <  0.05),  and 
**significantly different from Compound K-treated cells (p < 0.05). 
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2.2. Induction of Apoptosis by Compound K via a Mitochondria-Dependent Pathway   
Such increases in intracellular ROS cause loss of mitochondria membrane permeability, resulting in 
the induction of apoptosis
 [40,41]. We investigated whether the  cytotoxicity of Compound  K was 
associated  with  the  induction  of  apoptosis.  Sub  G1-hypodiploid  cells,  which  are  an  indicator  of 
apoptosis, increased in Compound K-treated cells as compared to control cells (Figure 4A). Apoptotic 
pathway  requires  the  alteration  of  the  mitochondrial  membrane  potential  (Δψm),  which  leads  to 
mitochondrial membrane permeabilization and is followed by a release of cytochrome c and caspases 
activation
 [4,42]. Compound K-treated cells exhibited a loss of Δψm, as substantiated by an increase 
of fluorescence intensity in  fluorescence (FL-1) using the JC-1 dye (Figure 4B). In non-apoptotic 
cells, the monomer form of JC-1 accumulates as aggregates in the mitochondria, which then emits red 
fluorescence; whereas in apoptotic cells, JC-1 does not accumulate and remains a monomer, emitting 
green fluorescence. The control cells exhibited strong red fluorescence in the mitochondria; however, 
Compound K-treated cells resulted in a decreased red fluorescence in the mitochondria and increased 
green fluorescence, suggesting that Compound K treatment disrupted the mitochondrial Δψ (Figure 
4C).  During the apoptotic process,  Bcl-2,  an anti-apoptotic regulator, prevents  the opening of the 
mitochondrial membrane pores, whereas Bax, an apoptotic regulator, induces it
 [43]. Compound K was 
shown  to  increase  Bax  expression  while  decreasing  that  of  Bcl-2  expression.  Therefore,   
Compound K-induced loss of the Δψm may have been a result of an up-regulation of Bcl-2 and a 
down-regulation of Bax. The pore opening induces the loss of the Δψm, which in turn induces the 
release  of  cytochrome  c  from  the  mitochondria  [44,45].  Compound  K  induced  the  release  of 
cytochrome c from mitochondria into cytosol (Figure 4D). The mitochondrial membrane disruption by 
Compound  K  activated  caspase-9  (37  and  39  kDa)  and  caspase-3  (19  and  17  kDa),  a  target  of   
caspase-9, which was further demonstrated by PARP cleavage (89 kDa) (Figure 4D). These results 
suggest that Compound K induced apoptosis via a caspase--dependent pathway in the mitochondria. 
Further, Compound K-induced decreases in the Bcl-2 protein and corresponding increases in the Bax 
protein, results in the opening of mitochondrial membrane pores, facilitating the release of cytochrome 
c from mitochondria into cytosol. Cytochrome c is bound to the outer surface of the inner membrane 
phospholipids.  An  early  process  in  the  release  of  cytochrome  c  is  its  dissociation  from  the  inner 
membrane. Mitochondrial ROS have been shown to promote cytochrome c release to the cytosol by 
dissociation  from  these  membrane  phospholipids
 [46,47].  Therefore,  Compound  K-mediated  ROS 
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Figure  4.  Induction  of  mitochondria-dependent  and  caspase-dependent  apoptosis  by 
Compound K treatment. (A) Apoptotic sub-G1 cells were detected by flow cytometry after 
PI staining. (B) Δψm was analyzed by flow cytometry and (C) confocal microscopy after 
staining  cells  with  JC-1  dye.  (D)  Cell  lysates  were  electrophoresed  and  Bax,  Bcl-2, 
cytochrome c, active caspase-9, active caspase-3, and cleaved PARP proteins were detected 
using their corresponding antibodies. 
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Figure 4. Cont. 
 
2.3. Induction of Apoptosis by Compound K via JNK and p38 MAPK Activation 
Various studies have suggested a possible mechanism for the JNK and p38 MAPK pathway, as 
related  to  mitochondrial  depolarization  and  apoptosis  induction
 [48].  The  activated  MAPK  family 
members including the phosphorylated form of p38, JNK, and ERK are common components of the 
apoptotic process
 [49–51]. Some reports have shown that ROS acted as upstream regulators, resulting 
in  the  activation  of  p38  MAPK  and  JNK
  [52,53].  Intracellular  ROS  are  also  upstream  of 
AMP-activated protein kinase (AMPK) activation [54]. AMPK is highly sensitive to oxidative stress 
because increased cellular ROS change the AMP level, which leads to rapid AMPK activation. The 
involvement of AMPK in the inhibition of carcinogenesis can modulate the regulation of COX-2 [55]. 
Our previous study demonstrated that Compound K exhibited apoptosis by ROS-mediated AMPK 
activation in MCF-7 breast cancer cells [23]. In the present study, Compound K induced the activation 
of  JNK  and  p38  MAPK  in  a  time-dependent  manner  (Figure  5A).  We  then  examined  whether  a 
specific inhibitor of JNK and p38 MAPK could attenuate cell death through activation of JNK and p38 
MAPK  signaling  by  Compound  K.  Results  revealed  that  SP600125  (an  inhibitor  of  JNK)  and 
SB203580 (an inhibitor of p38 MAPK) attenuated the cytotoxic effect of Compound K (Figure 5B). 
Likewise, siJNK and sip38-transfected cells abolished the cytotoxic effect of Compound K (Figure 5C). 
Our  results  revealed  that  phospho  p38  MAPK  and  phospho  JNK  were  notably  increased  after 
Compound  K  treatment.  In  contrast,  Compound  K  treatment  reduced  the  level  of  phospho  ERK 
expression (data not shown). This suggested that activation of p38 MAPK and JNK was related to 
Compound K-induced apoptotic cell death. These results indicate that JNK and p38 MAPK may play a 
role in Compound K-induced cytotoxicity in HT-29 cells. Int. J. Mol. Sci. 2010, 11                  
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Figure 5. Effect of Compound K on the MAPK signaling pathway. (A) Cell lysates were 
electrophoresed and were immunoblotted using anti-JNK, -phospho JNK, -p38, and 
-phospho p38 antibodies. (B) After treatment with MAPK inhibitors or/and Compound K, 
cell viability was assessed by MTT assay. (C) After transfection of siRNA against MAPK, 
and/or Compound K, cell viability was assessed by MTT assay. *Significantly different 
from  control  (p  <  0.05),  and  **significantly  different  from  Compound  K-treated 
cells (p < 0.05). 
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3. Experimental Section 
3.1. Chemicals   
Compound K was provided by professor Dong Hyun Kim (Kyung Hee University, Seoul, Korea). 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium]  bromide  (MTT),  2′,7′-dichlorodihydro-
fluorescein  diacetate  (DCF-DA),  N-acetylcysteine  (NAC),  propidium  iodide,  SP600125,  and 
SB203580 were purchased from Sigma Chemical Co. (St. Louis, MO, USA). 5,5′,6,6′-Tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine chloride (JC-1) was purchased from Molecular Probes 
(Eugene,  OR,  USA).  The  primary  anti-Bcl-2,  -Bax,  -cytochrome  c,  -caspase-9,  -caspase-3,  -poly   
ADP-ribosyl  polymerase  (PARP),  -c-Jun  NH2-terminal  kinase  (JNK),  -phospho  JNK,  -p38, 
and -phospho p38 antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). 
3.2. Cells and Cell Culture 
Human colon adenocarcinoma (HT-29) and normal colon cells (FHC), from the American type 
culture collection (Rockville, MD, USA), were maintained at 37 °C  in an incubator with a humidified 
atmosphere of 5% CO2 and cultured in RPMI 1640 medium containing 10% heat-inactivated fetal calf 
serum, streptomycin (100 μg/mL), and penicillin (100 units/mL).   
3.3. Cell Viability Assay 
The effect of Compound K on the viability of the cells was determined by the MTT assay, which is 
based on the reduction of a tetrazolium salt by mitochondrial succinatedehydrogenase in viable cells 
[56]. The cells were seeded in a 96 well plate at a density of 1  10
5 cells/mL, treated with Compound 
K, and after incubating for 48 h, 50 μL of the MTT stock solution (2 mg/mL) was added to each well 
to attain a total reaction volume of 250 μL. After an incubation of 4 h, the supernatants were aspirated. 
The  formazan  crystals  in  each  well  were  then  dissolved  in  150  μL  dimethylsulfoxide,  and  the 
absorbance at 540 nm was read on a scanning multi-well spectrophotometer.   
3.4. Measurement of Intracellular Reactive Oxygen Species (ROS) 
The DCF-DA method was used to detect the levels of intracellular ROS
 [42]. Cells were seeded 
onto a 96 well plate at 2  10
4 cells/well. The day after plating, the cells were treated with NAC 
(2 mM) for 30 min and then treated with Compound K for 24 h. After the addition of 25 mM of the 
DCF-DA  solution  for  20  min,  the  fluorescence  of  2′,7′-dichlorofluorescein  was  measured  using  a 
Perkin Elmer LS-5B spectrofluorometer. 
3.5. Detection of Sub-G1 Hypodiploid Cells 
The amount of apoptotic sub-G1 hypodiploid cells was determined by flow cytometry [57]. Cells 
were treated with Compound K for 48 h. Harvested cells were then washed twice with phosphate 
buffered saline (PBS) and fixed in 70% ethanol for 30 min at 4 ° C. Subsequently, the cells were Int. J. Mol. Sci. 2010, 11                  
     
4926 
incubated in 50 mg/mL propidium iodide solution and 50 μg/mL RNase A in the dark for 30 min at 
37 ° C. A flow cytometric analysis was  performed using a FACS Calibur  flow cytometer (Becton 
Dickinson,  Mountain  View,  CA,  USA).  The  sub-G1  hypodiploid  cells  were  assessed  based  on 
histograms generated by Cell Quest and Mod-Fit computer programs. 
3.6. Analysis of Mitochondrial Membrane Potential (Δψm) 
Cells were stained with JC-1 (10 μg/mL), and were then analyzed using flow cytometry
 [58]. In 
addition, for image analysis, the JC-1-stained cells were mounted with mounting medium (DAKO, 
Carpinteria, CA, USA). Microscopic images were collected using the Laser Scanning Microscope 5 
PASCAL program (Carl Zeiss, Jena, Germany) on a confocal microscope. 
3.7. Western Blot Analysis   
Harvested cells were washed in PBS, lysed in a lysis buffer [120 mM NaCl, 40 mM Tris (pH 8), 
0.1% NP 40] and then centrifuged at 13,000 ×  g for 15 min. Aliquots of the lysates (50 μg of protein) 
were  boiled  at  95  °C   for  5  min  and  electrophoresed  on  SDS–polyacrylamide  gels.  Gels  were 
transferred onto nitrocellulose membranes for blotting (Bio-Rad, CA, USA), and the membranes were 
then  incubated  with  primary  antibodies.  The  membranes  were  further  incubated  with  secondary 
immunoglobulin  G-horseradish  peroxidase  conjugates,  and  then  underwent  enhanced 
chemiluminescence using a Western blotting detection kit (Amersham, Buckinghamshire, UK). The 
protein bands were visualized using luminescent image analyzer. 
3.8. Transient Transfection of Small RNA Interference (siRNA) 
Cells were seeded at 1.5 ×  10
5 cells/well in 24 well plate and allowed to reach approximately 50% 
confluence on the day of transfection. The siRNA construct used were obtained as mismatched siRNA 
control (siControl, Santa Cruz Biotechnology, Santa Cruz, CA, USA), siRNA against JNK, and p38 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells were transfected with 10–50 nM siRNA 
using lipofectamineTM 2000 (Invitrogen, Carlsbad, CA, USA) based on the manufacturer’s instruction. 
At 24 h after transfection, the cells were treated with Compound K for 48 h and examined by either 
Western blot analysis or MTT assay.   
3.9. Statistical Analysis   
All the measurements were performed in triplicate and all values were represented as the mean 
standard error (SE). Results were subjected to an analysis of the variance (ANOVA) using the Tukey 
test for analysis of the differences. Statistical significance was set at p > 0.05. Int. J. Mol. Sci. 2010, 11                  
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4. Conclusions 
This study demonstrated that Compound K-mediated generation of ROS led to apoptosis through 
activation of p38 MAPK and JNK, which modulate the expression of Bcl-2 and Bax, and then trigger 
loss of mitochondrial membrane potential, cytochrome c release, and caspase activation. 
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